For instance, in November 2023, results from the SELECT trial published in the New England Journal of Medicine showed that once-weekly semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease without diabetes, highlighting the expanding role of long-acting GLP-1 analogues beyond glycemic control into cardiovascular risk reduction
2010 Jul;10 Suppl 1:S99-106
Radiographic assessment, callus surface measurement, microphotodensitometry, and quantitative histomorphometry all confirmed the effect
Japan Glucagon-Like Peptide 1 (GLP-1) Agonists Market Insight The Japan Glucagon-Like Peptide 1 (GLP-1) Agonists market is witnessing consistent growth due to increasing prevalence of metabolic disorders, an aging population, and strong adoption of innovative diabetes treatment solutions
Epitalon Injection vs
Maternal plasma folate, vitamin B12 levels and multivitamin supplementation during pregnancy and risk of Autism Spectrum Disorder in the Boston Birth Cohort. The FASEB Journal 30 (2016): 151-6